Molecular Landscape of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

The Molecular Biology of Diffuse Large B-Cell Lymphoma

Therapeutic Advances in Hematology
Hematology
2011English

Diffuse Large B-Cell Lymphoma

2020English

Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

British Journal of Haematology
Hematology
2014English

Pathophysiology and Molecular Aspects of Diffuse Large B-Cell Lymphoma

Revista Brasileira de Hematologia e Hemoterapia
2012English

Molecular Analysis of a CD19-negative Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2018English

Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Current Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy